NSE seeks clarification on Q4 FY26 results

ALPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹68.50

prior close

₹68.94

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%+0.6% vs market

Pharmaceuticals peers, median of 163sector-0.6%+0.6% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0-0.6+0.6-0.6+0.6

Next day

-1.4-0.9-0.5-0.3-1.1

-1.6+0.1-1.7+0.5-2.1

+0.0+0.3-0.3+0.0-0.0

+1.0+1.2-0.1+0.3+0.7

-0.1+0.8-1.0+1.3-1.4

-0.7+0.3-1.0+0.1-0.8

15d

+0.1-0.2+0.4+1.0-0.8

-2.3+0.6-2.9+0.8-3.1

-9.0+4.7-13.7+1.4-10.4

-14.6+5.4-20.0+5.6-20.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NSE has asked Alpa Laboratories to clarify certain points about its financial results for the quarter ended 31 March 2026, under SEBI Listing Regulations. The company has not yet responded. The query is related to Regulation 33 which covers submission of financial results.

Likely market impact

Routine exchange query, no penalty or action disclosed yet. Investors should wait for the company's clarification.